The potential use of ABO blood group system for risk stratification of COVID-19.
The potential use of ABO blood group system for risk stratification of COVID-19.
复制标题
DOI:
10.1016/j.mehy.2020.110343
复制
发表时间:
2020-12
影响因子:
4.7
通讯作者:
Fouda R
中科院分区:
文献类型:
--
作者:
AbdelMassih AF;Mahrous R;Taha A;Saud A;Osman A;Kamel B;Yacoub E;Menshawey E;Ismail HA;Aita L;Dous M;Saad M;AbdelAziz M;Zaghar M;Shebl N;El-Husseiny N;Fahmy N;Hegazy N;Khalid O;Saad O;Afdal P;Menshawey R;Husseiny R;Sherien S;Salama S;Gad S;Ali S;Maalim S;Ismail S;ElHefnawi Y;Aziz Y;Fouda R
ABO blood groups is a cheap and affordable test that can be immediately retrieved from COVID-19 patients at the diagnosis. There is increasing evidence that non-O blood groups have both higher susceptibility and higher severity of COVID-19 infections. The reason behind such relationship seems elusive. Regarding susceptibility, Non-O individuals have Anti-A antibodies which can prevent viral entry across ACE-2 receptors, moreover, Non-O individuals are at higher risk of autoimmunity, hypercoagulable state, and dysbiosis resulting in an augmented tendency for vascular inflammatory sequelae of COVID-19. We can conclude, on the diagnostic level, that ABO blood groups can be potentially used for risk stratification of affected COVID-19 patients, to anticipate the deterioration of patients at higher risk for complications. On a therapeutic level, plasma from normal O blood group individuals might potentially replace the use of convalescent serum for the treatment of COVID-19.
登录
查看更多内容
影响因子:
--
作者:
AbdelMassih, Antoine Fakhry;Ye, Jianping;Fouda, Raghda
通讯作者:
Fouda, Raghda
影响因子:
2.9
作者:
Garratty, G;Glynn, SA;McEntire, R
通讯作者:
McEntire, R
影响因子:
2.7
作者:
Huang, Lin;Wang, Teng;Wan, Qi
通讯作者:
Wan, Qi
DOI:
10.1016/j.numecd.2014.10.015
发表时间:
2015-04-01
影响因子:
3.9
作者:
Li, Sha;Xu, Rui-Xia;Li, Jian-Jun
通讯作者:
Li, Jian-Jun
影响因子:
2.5
作者:
Hong, Xu-Lin;Li, Ya;Zhang, Wen-Bin
通讯作者:
Zhang, Wen-Bin